Table 2.

Medical Professional Satisfaction Questionnaire

Question	Response
1). Do you find this Program the most suitable solution to deal with patients in treatment with secukinumab?	Score a
2). In which of the following aspects do you feel more supported?
a. Is the patient more followed and aware?	Yes/No
b. Are the monitoring visits taking less time?	Yes/No
c. Could you get more information about the patients’ disease management?	Yes/No
d. Any other relevant aspect?	Yes/No
3). If Yes to question 2a, in which aspect do you find the patient more followed and aware?
a. Management of secukinumab	%
b. Management of side effects	%
c. Management of the dermatological aspect	%
d. Management of the psychological aspect	%
e. Management of the nutritional aspect	%
f. Others	%
4). If Yes to question 2b, what is the average time saved at each monitoring visit?
a. <5 minutes	%
b. 5–10 minutes	%
c. 10–20 minutes	%
d. >20 minutes	%
5). If Yes to question 2c, which kind of information did you get thanks to the Program?
a. Patient adherence	%
b. Compliance with the recommendations	%
c. Side effects	%
d. Other? If yes, which aspects could you mention?	%
6). If Yes to question 2d, which kind of information could you get thanks to the Program in addition to the ones yet mentioned?
7). What is your opinion about the overall quality of the Program?	Score a

Notes: ^a1 – Did not meet my expectations; 2 – Fairly Satisfactory; 3 – Satisfactory; 4 – Very Satisfactory; 5 – Outstanding.